FdaApplication
ANDA 202727
Identifiers
- fda_app_no: ANDA202727
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS INC USA |
| application_type | ANDA |
| approval_date | 2012-05-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LANSOPRAZOLE | LANSOPRAZOLE | 15MG | CAPSULE, DELAYED REL PELLETS;ORAL |
1 product